Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Liuwei Shunji
- Development stage
- Unknown
- Lead developer
- Guangdong Songshan Lake ZhenDe Biomedical Technology
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Liuwei Shunji is a Traditional Chinese Medicine (TCM) herbal formulation developed by Guangdong Songshan Lake ZhenDe Biomedical Technology for the treatment of irritable bowel syndrome (IBS). Administered as an oral capsule, the formulation is designed to regulate gastrointestinal motility and alleviate symptoms such as abdominal pain and irregular bowel movements. Clinical development in China has progressed through Phase II trials (e.g., CTR20131452), which aimed to establish the safety, efficacy, and optimal dosing required for subsequent Phase III clinical evaluation. As a TCM product, its therapeutic effect is attributed to the synergistic properties of its six primary herbal ingredients, traditionally used to harmonize 'Qi' and improve digestive health.
- Brand names
- Liuwei Shunji
- Other names
- Liuwei Shunji Capsule六味顺气胶囊
Beyond the preview
Go deeper on Liuwei Shunji.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Liuwei Shunji.